On Friday 24 February 2017 Business Sweden and InvestHK host a seminar in Stockholm Sweden: The Karolinska Institutet Node in Hong Kong, a springboard to Asia.
In 2016 Karolinska Institutet’s Ming Wai Lau Centre for Reparative Medicine in Hong Kong was inaugurated.
The seminar, held at the World Trade Center, features the following speakers and seminar highlights:
Helena Storm, Consul General of Sweden gives open remarks on Sweden and Hong Kong relation and cooperation
Ebba Hult, Head of Business Development Health Care & Life Science at Business Sweden introduces the Swedish government and industry initiative “SymbioCare-Health by Sweden”, established with the purpose to promote Swedish healthcare and life science internationally and to spur international collaborations.
Van Hoang, Trade Commissioner and Country Manager to Hong Kong and Macau at Business Sweden shares the Swedish perspective on current and future business climate in Hong Kong; advantages and challenges in doing business in Hong Kong. The most interesting markets in the region for Swedish companies having Hong Kong as a base and Asia hub are also highlighted.
Professor Ronald Li, Director, Hong Kong node, Ming Wai Lau Centre, Karolinska Institute shares his experience of how Karolinska Institutet landed in Hong Kong and gives some insights about some of his game changing research initiatives.
Dr Ola Hermanson, ‘Scientific Director, Ming Wai Lau Centre, Karolinska Institute and researcher at the Department of Neuroscience at Karolinska Institutet in Sweden explains the opportunities for collaboration with KI.
Marian Gaultney, Head of International Collaboration & Business Development at HKSP, gives an overview on Hong Kong’s research and innovation initiatives, as well as the various programmes at the Science Park.
Madelene Kornfehl, the Nordic Consultant of Hong Kong Trade Development Council tells you the services of Hong Kong Trade Development Council.
Charles Ng, Associate Director General from Invest Hong Kong gives an update on how Hong Kong is becoming one of the world’s fastest growing innovation and high tech entrepreneurship ecosystems and the support available for innovative enterprises looking to set up in the city and use Hong Kong as a laboratory, a showcase and a global launchpad.
The life science sector has never been so global and there is an increasing need for international collaborations and entering high growth markets outside Europe. Seminar participants get to to learn about the exciting opportunities to grow and scale a profitable business in Asia leveraging on Karolinska Institutet’s Ming Wai Lau Centre for Reparative Medicine in Hong Kong.
The successful set up of the centre at the Hong Kong Science Park (HKSP) is a strong commitment, and demonstration of Sweden’s determination to accelerate cutting edge research initiatives in Asia in the areas of stem cell biology, biomedical engineering and regenerative medicine. KI-MWLC-HK is expected to result in numerous new breakthroughs and innovations while at the same time strengthen the ties between Sweden and Hong Kong as well as open doors for collaborations in other parts of Asia.